Tag: FDA generic standards

10, August, 2026

Narrow Therapeutic Index Drugs: Why Stricter Bioequivalence Rules Matter for Your Health

Explore why Narrow Therapeutic Index (NTI) drugs require stricter bioequivalence standards. Learn about FDA, EMA, and Health Canada regulations, the impact on patient safety, and future harmonization efforts.